Risk Factors for Amisulpride-Associated Hyperprolactinemia: Gender-Specific Plasma Concentration Cutoffs Derived from ROC Analysis

Hui Wang, Qing Shao, Miaomiao Yang, Yichen Chen, Wenjie Wang · 2026

Read Risk Factors for Amisulpride-Associated Hyperprolactinemia: Gender-Specific Plasma Concentration Cutoffs Derived from ROC Analysis by Hui Wang, Qing Shao, Miaomiao Yang, Yichen Chen, Wenjie Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13541070.txt.

Description

The drug amisulpride often raises prolactin, a hormone that can cause unwanted effects, and Hui Wang's team looked for who is most at risk. They reviewed records from 209 patients taking the drug. Dose, blood levels, sex, and two companion drugs all played a part.

Higher doses meant higher blood levels, and higher levels meant higher prolactin. The team set a screening cutoff of 28 ng/mL for prolactin itself. For the drug's blood level, the safe-looking threshold was higher in women than in men: 317.8 versus 294.2 ng/mL. Those numbers can guide dose checks for each patient.

Catalog record

CREATORHui Wang, Qing Shao, Miaomiao Yang, Yichen Chen, Wenjie Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13541070

Browse the full library · About the Tower of Babel